• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Koo
  • Youtube
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

Tag: Moderna

Moderna Sues Pfizer
Moderna sues Pfizer, BioNTech over patent infringement of its Covid vaccine

Biotechnology major Moderna on Friday sued rival Pfizer and BioNTech over alleged infringement of its messenger RNA (mRNA) vaccine technology patents.

  • Friday, 26 August 2022
Moderna's new Covid vax more effective against Omicron than other shots
Moderna's new Covid vax more effective against Omicron than other shots

According to the US drug major, the new vaccine targets several mutations abd produced a stronger immune response against the major virus variants, including Omicron and Delta, than the company's current shots, CNBC reported.

  • Wednesday, 20 April 2022
Moderna Working On Jab Against Covid, Flu
Moderna Working On Jab Against Covid, Flu

Moderna is currently also developing a vaccine to specifically tackle the Omicron variant. Early-stage data on its effectiveness is expected within the next two weeks.

  • Sunday, 09 January 2022
US Authorises Pfizer, Moderna Covid-19 Vaccine Boosters For All Adults
US Authorises Pfizer, Moderna Covid-19 Vaccine Boosters For All Adults

Moderna requested authorisation of its 50 microgram booster dose for all adults on Wednesday. The company said the FDA based the emergency use authorisation (EUA) on the "totality of scientific evidence shared by the company," including data that showed neutralizing antibodies had waned at about six months.

  • Saturday, 20 November 2021
Moderna COVID19 Vaccine Efficacy Marginally Drops To 90% In US Trial
Moderna COVID19 Vaccine Efficacy Marginally Drops To 90% In US Trial

New York: Updated results from an ongoing Phase 3 clinical trial in the US have shown Moderna’s Covid-19 vaccine to be 90 per cent effective against all cases of the…

  • Wednesday, 14 April 2021
WHO Panel To Issue Recommendations On Moderna's Covid-19 Vaccine
WHO Panel To Issue Recommendations On Moderna's Covid-19 Vaccine

Geneva: A World Health Organization (WHO) panel of vaccine experts is set to issue recommendations on Moderna’s Covid-19 vaccine on Tuesday. The WHO had granted emergency use validation for the Pfizer-BioNTech Covid-19 vaccine on December 31, 2020, opening the door for countries to expedite their own regulatory approval processes to import and administer the vaccine. […]

  • Tuesday, 06 April 2021
Kamala Harris
Kamala Harris Receives First Dose Of Moderna Covid-19 Vaccine

Washington: US Vice President-elect Kamala Harris has received the first dose of the Moderna vaccine against the novel coronavirus. According to the Biden-Harris transition team, Harris was vaccinated on Tuesday by Patricia Cummings, a clinical nurse manager at the United Medical Center. In a tweet late Tuesday, Harris said: “Today I got the Covid-19 vaccine. […]

  • Wednesday, 07 April 2021
US Approves Moderna Covid-19 Vaccine For Emergency Use
US Approves Moderna Covid-19 Vaccine For Emergency Use

New York: The United States on Friday authorised a second Covid-19 vaccine in a single week’s time, green lighting a shot developed by Moderna Inc. and the National Institutes of Health for emergency use in Americans of 18 years and older. The Moderna approval comes exactly a week after the US Food and Drug Administration […]

  • Monday, 01 March 2021
Oxford Covid-19 Vaccine ‘Encouraging' For Older Age Groups
Covid-19 Vaccine: Odisha May Face Cold Chain Challenge

Bhubaneswar: Even as the race of potential vaccine for Covid-19 is approaching the last lap, the cold-chain infrastructure is likely to emerge as biggest hurdle for Odisha, say experts. The State government has started a road map in full swing for procurement, preservation and distribution of the vaccine as Prime Minister Narendra Modi on Friday […]

  • Friday, 09 April 2021
Indian Health Experts Hail mRNA Vaccine For Covid Treatment
Indian Health Experts Hail mRNA Vaccine For Covid Treatment

New Delhi: With the two mRNA vaccine candidates from pharma giants Pfizer-BioNTech and Moderna showing effectiveness in preventing Covid-19 in an interim analysis, health experts in India on Tuesday said that mRNA vaccine that works on previously unproven technology can be very promising in the fight against the pandemic despite the challenges. To date, no […]

  • Friday, 09 April 2021
Allergic Reactions
Moderna's COVID-19 Vaccine Shows 94.5% Efficacy In US Tests

Cambridge: Moderna said on Monday that its COVID-19 vaccine shots provide strong protection which is a dash of hope against the grim backdrop of coronavirus surges in the US and around the world. Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from the company’s still ongoing study. A week ago, […]

  • Friday, 09 April 2021
Moderna-COVID19-Vaccine
Moderna Prepares Global Launch Of Covid-19 Vaccine

Washington: American biotechnology company Moderna announced that it was preparing for the global launch of its Covid-19 vaccine candidate. “We are actively preparing for the launch of mRNA-1273 and we have signed a number of supply agreements with governments around the world,” Xinhua news agency quoted Moderna CEO Stephane Bancel as saying in a statement […]

  • Saturday, 10 April 2021
Moderna-COVID-Vaccine
Covid-19 Vaccine: Moderna To Supply 40 Million Doses Of Vax To Japan

New York: The US-based biotech company Moderna has confirmed talks to supply 40 million doses of its potential Covid-19 vaccine to Japan. Under the terms of this arrangement, the vaccine, mRNA-1273, would be supplied by Moderna and distributed in Japan by Takeda Pharmaceutical Co. Ltd. beginning in the first half of 2021, if the vaccine […]

  • Tuesday, 13 April 2021
COVID-19-vaccine
COVID-19 Treatment: Moderna's Coronavirus Vaccine Shows Early Promise In Human Trial, Stock Soars

New York: In a ray of hope against Covid-19, an mRNA vaccine under human clinical trial by Massachusetts-bases biotechnology giant Moderna has shown promising results by generating an immune-system response in the body to fight coronavirus. mRNA-1273 is an mRNA vaccine against SARS-CoV-2 which was selected by Moderna in collaboration with investigators from the Vaccine […]

  • Friday, 16 April 2021
scrollToTop

AdBlock Detected!

Our website is made possible by displaying ads to our visitors. Please supporting us by whitelisting our website.